An evaluation into the use of procalcitonin levels as a biomarker of bacterial sepsis to aid the management of intrapartum pyrexia and chorioamnionitis

BACKGROUND: Procalcitonin is an established biomarker for bacterial sepsis in the nonpregnant population with better diagnostic and prognostic value for bacterial infections. OBJECTIVE: This study aimed to evaluate whether procalcitonin levels could be used in the diagnosis and management of intrapa...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Sarah, Harding, Irasha, Soomro, Kamran, Bamber, Andrew R., Carrick, Sophie, Waheed, Abdul H., Liebling, Rachel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563784/
https://www.ncbi.nlm.nih.gov/pubmed/36276783
http://dx.doi.org/10.1016/j.xagr.2022.100064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563784/
https://www.ncbi.nlm.nih.gov/pubmed/36276783
http://dx.doi.org/10.1016/j.xagr.2022.100064

Ejemplares similares